Cardiol Therapeutics Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Depreciation and Depletion 0.11M0.11M0.10M0.12M0.12M
Share-based Compensation 2.06M6.78M3.86M3.08M10.43M
Cash from Operations -6.81M-18.78M-20.94M-18.66M-18.30M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.06M0.07M0.06M0.06M0.15M
Depreciation & Amortization (CF) 0.11M0.11M0.10M0.12M0.12M
Change in Working Capital
Change in Receivables 0.52M-0.10M-0.11M0.10M-0.09M
Change in Inventory 0.82M0.01M
Change in Account Payables 1.36M1.91M3.44M-0.96M-0.78M
Other Working Capital Changes -0.05M-1.71M1.04M0.41M0.16M
Investing Activities
Capital Expenditures 0.03M0.01M0.06M0.05M0.02M
Cash from Investing Activities -0.03M-0.01M-0.06M-0.05M-0.02M
Financing Activities
Other financing activities -0.81M-4.18M
Cash from Financing Activities 12.16M74.56M-0.04M-0.04M13.76M
Additional items
Exchange Rate Effect -0.01M2.25M0.56M1.38M
Change in Cash 5.32M55.77M-21.04M-18.75M-4.56M
Beginning Cash Balance -5.32M11.18M21.04M18.75M4.56M
Free Cash Flow -6.85M-18.79M-20.99M-18.71M-18.32M
Net Cash Flow 5.32M55.77M-21.04M-18.75M-4.56M